Bioceres offers fully-integrated crop solutions including patented technologies for seeds and microbial ag-inputs anchored by HB4® technology, the world's only drought-tolerant soybeans and wheat. Operating in over 40 countries with primary focus in Argentina, Brazil, the US, Europe, and South Africa, Bioceres maintains a leading position serving world's largest agricultural markets.
Cyborg Score Rationale
Q1 FY2026 revenues declined 17% YoY to $77.5M due to planned transition away from low-margin sales. However, gross margins expanded to 47% and Adjusted EBITDA increased 61% YoY, demonstrating profitability improvement despite revenue headwinds.
Top Insights
Strategic pivot toward high-margin products showing early success with 47% gross margins and 61% EBITDA growth despite 17% revenue decline
HB4® proprietary technology provides competitive differentiation as world's only drought-tolerant soybean and wheat platform with global addressable market
Argentina market conditions showing early signs of normalization after challenging period
Historic achievement as first Latin American biotech company listed on NYSE, establishing credibility and access to capital markets
Named Competitors
Integrated Agricultural Solutions — Global seeds, crop protection, and crop nutrition
Crop Nutrients — Leading fertilizer and crop nutrient provider
Agricultural Biologicals — Biological products and bio-based agricultural solutions
Recent Developments
(November 2025) Q1 FY2026 results showed margin expansion to 47% and 61% YoY EBITDA growth despite planned 17% revenue decline
(February 2025) Q2 FY2025 preliminary guidance of $105M revenues with $45M gross profit
(March 2019) Listed on NYSE American under ticker BIOX, becoming first Latin American biotech company on NYSE
Open the full interactive Bioceres Crop Solutions Corp. report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.